tradingkey.logo

Evaxion Biotech A/S

EVAX
5.130USD
+0.210+4.27%
Close 12/26, 16:00ETQuotes delayed by 15 min
1.62BMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Evaxion Biotech A/S to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q1
FY2019Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
30.69%-5.19M
-102.87%-8.19M
6.33%-4.12M
---6.29M
---7.49M
-36.78%-4.04M
-98.42%-4.39M
---2.95M
---2.21M
Net income from continuing operations
30.08%-4.77M
-41.49%-5.79M
-96.29%-8.37M
---5.25M
---6.82M
-32.07%-4.09M
-21.17%-4.26M
---3.10M
---3.52M
Operating gains losses
----
----
----
----
----
----
-3.33%29.00K
----
--30.00K
Other non-cash items
-1271.43%-820.00K
86.81%-129.00K
484.26%1.59M
---138.00K
--70.00K
-292.90%-978.00K
-311.79%-413.00K
--507.00K
--195.00K
Change in working capital
157.86%427.00K
-308.96%-2.17M
1952.67%2.69M
---906.00K
---738.00K
389.94%1.04M
-81.34%131.00K
---358.00K
--702.00K
-Change in receivables
----
----
--846.00K
----
----
----
-100.00%0.00
----
--688.00K
-Change in other current assets
----
----
----
----
----
----
--20.00K
----
--0.00
Cash from non-recurring investing activities
Cash from operating activities
30.69%-5.19M
-102.87%-8.19M
6.33%-4.12M
---6.29M
---7.49M
-36.78%-4.04M
-98.42%-4.39M
---2.95M
---2.21M
Investing cash flow
Net cash from continuing investing activities
-83.73%83.00K
-47.08%181.00K
144.44%176.00K
--332.00K
--510.00K
434.38%342.00K
53.19%72.00K
--64.00K
--47.00K
Capital expenditures
-83.73%83.00K
-47.08%181.00K
144.44%176.00K
--332.00K
--510.00K
434.38%342.00K
53.19%72.00K
--64.00K
--47.00K
Net cash flow from disposal of fixed assets
-83.73%83.00K
-35.82%181.00K
144.44%176.00K
--332.00K
--510.00K
340.63%282.00K
53.19%72.00K
--64.00K
--47.00K
Net cash flow from intangible asset transactions
--0.00
-100.00%0.00
--0.00
--0.00
--0.00
--60.00K
--0.00
----
----
Net cash flow from other investing activities
-60.00%6.00K
46.67%22.00K
99.52%-1.00K
--1.00K
--15.00K
188.24%15.00K
---209.00K
---17.00K
----
Cash from non-current investing activities
Net cash flow from investing activities
84.44%-77.00K
51.38%-159.00K
37.01%-177.00K
---331.00K
---495.00K
-303.70%-327.00K
-497.87%-281.00K
---81.00K
---47.00K
Financing cash flow
Cash flow from continuous financing activities
-757.14%-300.00K
-69.36%7.74M
938.46%24.65M
---65.00K
---35.00K
140388.89%25.25M
872.95%2.37M
---18.00K
--244.00K
Net cash flow from debt Issuance/repayment
-205.71%-107.00K
18095.35%7.74M
-620.00%-144.00K
---67.00K
---35.00K
-138.89%-43.00K
-11.11%-20.00K
---18.00K
---18.00K
Net cash flow from common stock issuance/repurchase
--28.00K
-100.00%0.00
984.09%25.95M
--1.00K
--0.00
--27.90M
137.97%2.39M
----
--1.01M
Net cash flow from other financing activities
---221.00K
100.00%0.00
---1.16M
--1.00K
--0.00
---2.60M
100.00%0.00
----
---744.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
-757.14%-300.00K
-69.36%7.74M
938.46%24.65M
---65.00K
---35.00K
140388.89%25.25M
872.95%2.37M
---18.00K
--244.00K
Net cash flow
Beginning cash balance
16.52%31.41M
451.35%32.17M
51.65%11.94M
--18.80M
--26.95M
-38.97%5.83M
-31.34%7.88M
--9.56M
--11.47M
Current period cash flow changes
24.51%-6.16M
-103.58%-757.00K
1090.30%20.22M
---6.86M
---8.16M
757.16%21.12M
-6.80%-2.04M
---3.21M
---1.91M
Effect of exchange rate changes
-327.54%-590.00K
-164.94%-150.00K
-153.88%-139.00K
---164.00K
---138.00K
240.00%231.00K
145.71%258.00K
---165.00K
--105.00K
Ending cash balance
34.33%25.25M
16.52%31.41M
451.35%32.17M
--11.94M
--18.80M
324.82%26.95M
-38.97%5.83M
--6.34M
--9.56M
Free cash flow
34.07%-5.27M
-91.16%-8.37M
3.90%-4.29M
---6.63M
---8.00M
-45.22%-4.38M
-97.48%-4.46M
---3.01M
---2.26M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI